Lv11
80 积分 2025-05-30 加入
nab-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
11小时前
待确认
Abstract PO-076: Murine adapted FOLFIRINOX for standard-of-care in KPC mice
4个月前
已完结
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer
6个月前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
7个月前
已完结
Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective
8个月前
已完结
N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions
8个月前
已关闭
Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration
9个月前
已完结
Metabolism of new drug modalities research advances – 2024 year in review
9个月前
已完结
Drug Targeting Towards the Lymphatics
9个月前
已完结
Drug Targeting Towards the Lymphatics
9个月前
已关闭
皖公网安备34019202002308
